Clinical Trial Update: Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating photodynamic therapy with HPPH for Barrett's Esophagus with high-grade dysplasia or carcinoma in situ has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Carcinoma in Situ

Drugs mentioned

• HPPH (photosensitizer) (HPPH)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Barrett's Esophagus, CIS | Phase 1 | Status: COMPLETED